Zila to launch Ester-E next year
US company Zila is planning to launch its Ester-E product in early 2004. The Ester-E technology is based upon a patented process for manufacturing tocopherol phosphate to create an enhanced form of vitamin E.
US company Zila is planning to launch its Ester-E product in early 2004. The Ester-E technology is based upon a patented process for manufacturing tocopherol phosphate to create an enhanced form of vitamin E.
The company has entered into a long-term license agreement with Australian biotech company Vital Health Sciences, giving it the exclusive rights in the dietary supplement market for certain issued and pending patents, know-how and data pertaining to tocopherol phosphate in the US, Canada and Indonesia. Under the agreement Zila also has a right of first refusal for other international markets for the life of the underlying patents, several of which were recently issued, while other patent applications are still pending.
Ester-E is created by combining natural d-alpha tocopherol with a phosphate molecule. The patented process is designed to protect the antioxidant potential of vitamin E during absorption, transport, and storage in the body to assist in the delivery of its nutritional benefits when needed. Preliminary studies conducted by Vital Health indicate potential advantages for tocopherol phosphate in absorption and in the support of cardiovascular health. Zila plans to conduct human clinical trials during 2004 to support the health benefits of Ester-E.
Zila will manufacture Ester-E at its Arizona facilities and initial product shipments are expected to roll out in early 2004.